|Videos|May 31, 2023
Interviews with Tim Tyson of TriRx at DCAT
Author(s)TriRx
Key Learning Objectives
- TriRx is redefining and evolving the perception of what a CDMO should be
- TriRx is continuously expanding its portfolio of world-class facilities to anticipate and meet customer needs
- Committed to openness, honesty, and transparency, TriRx gives customers total access to its people and processes
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
2
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
3
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
4
Women Leading Biotech: Advancing Treatments for Ovarian Cancer
5